IL1B and breast carcinoma: Garcia-Morales et al. [85] have also shown that cannabidiol (CBD) prevents breast cancer cell viability, blocks the IL-1β/IL-1RI/β-catenin signaling pathway, restores epithelial organization, and prevents nuclear translocation of β-catenin, ultimately indicating a potential therapeutic role for CBD in counteracting the malignant features induced by IL-1β.